Development of a multi-targeted sulfonyl-bridged bisselenadiazole derivative as a potent EGFR/PI3K/AKT/mTOR modulator in lung adenocarcinoma. - El-Fattah WA; Guesmi A; Ben Hamadi N; Sayed AR; El-Reedy AAM; Hafez HS; Elshaarawy RFM; Hassan SA (RSC advances, 2026)